Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarra Setrerrahmane

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Molecular Cancer|September 21, 2017
Tumor-related interleukins: old validated targets for new anti-cancer drug developmentSarra Setrerrahmane, Hanmei Xu
Oncology Reports|August 5, 2015
Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell lineChanghong Zhao, Sarra Setrerrahmane, Hanmei Xu
European Journal of Medicinal Chemistry|July 27, 2024
A peptide-salinomycin conjugate with a bystander effect reduces the stemness characteristics of ovarian cancer cells and enhances drug sensitivityChaowei Hao, Peng Chen, Sarra Setrerrahmane, et al.
Applied Biochemistry and Biotechnology|August 3, 2014
Efficient production of native lunasin with correct N-terminal processing by using the pH-induced self-cleavable Ssp DnaB mini-intein system in Escherichia coliSarra Setrerrahmane, Yi Zhang, Guangzhi Dai, et al.
Drug Design, Development and Therapy|November 30, 2017
Novel production method of innovative antiangiogenic and antitumor small peptides in <i>Escherichia coli</i>Sarra Setrerrahmane, Jian Yu, Jingchao Hao, et al.
Oncology Reports|September 17, 2016
In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude miceSitelbanat Yassin, Jialiang Hu, Hanmei Xu, et al.
Signal Transduction and Targeted Therapy|November 28, 2024
Nucleic acid drugs: recent progress and future perspectivesXiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Oncology Reports|April 24, 2020
[Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude miceSitelbanat Yassin, Jialiang Hu, Hanmei Xu, et al.
Signal Transduction and Targeted Therapy|July 6, 2022
Trends in insulin resistance: insights into mechanisms and therapeutic strategyMengwei Li, Xiaowei Chi, Ying Wang, et al.
Aging|December 28, 2023
The peptide Acein promotes dopamine secretion through <i>clec-126</i> to extend the lifespan of elderly <i>C. elegans</i>Jiaqi Wang, Dong Wang, Sarra Setrerrahmane, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Molecular Cancer|September 21, 2017
Tumor-related interleukins: old validated targets for new anti-cancer drug developmentSarra Setrerrahmane, Hanmei Xu
Oncology Reports|August 5, 2015
Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell lineChanghong Zhao, Sarra Setrerrahmane, Hanmei Xu
European Journal of Medicinal Chemistry|July 27, 2024
A peptide-salinomycin conjugate with a bystander effect reduces the stemness characteristics of ovarian cancer cells and enhances drug sensitivityChaowei Hao, Peng Chen, Sarra Setrerrahmane, et al.
Applied Biochemistry and Biotechnology|August 3, 2014
Efficient production of native lunasin with correct N-terminal processing by using the pH-induced self-cleavable Ssp DnaB mini-intein system in Escherichia coliSarra Setrerrahmane, Yi Zhang, Guangzhi Dai, et al.
Drug Design, Development and Therapy|November 30, 2017
Novel production method of innovative antiangiogenic and antitumor small peptides in <i>Escherichia coli</i>Sarra Setrerrahmane, Jian Yu, Jingchao Hao, et al.
Oncology Reports|September 17, 2016
In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude miceSitelbanat Yassin, Jialiang Hu, Hanmei Xu, et al.
Signal Transduction and Targeted Therapy|November 28, 2024
Nucleic acid drugs: recent progress and future perspectivesXiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Oncology Reports|April 24, 2020
[Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude miceSitelbanat Yassin, Jialiang Hu, Hanmei Xu, et al.
Signal Transduction and Targeted Therapy|July 6, 2022
Trends in insulin resistance: insights into mechanisms and therapeutic strategyMengwei Li, Xiaowei Chi, Ying Wang, et al.
Aging|December 28, 2023
The peptide Acein promotes dopamine secretion through <i>clec-126</i> to extend the lifespan of elderly <i>C. elegans</i>Jiaqi Wang, Dong Wang, Sarra Setrerrahmane, et al.
Pageof 2